Selected line difference in the effects of ethanol dependence and withdrawal on allopregnanolone levels and 5α-Reductase Enzyme Activity and Expression

Alcoholism: Clinical and Experimental Research

Volumn 33, Issue 12, 2009, Pages 2077-2087

  Tanchuck, Michelle A ^a   Long, Season L ^a   Ford, Matthew M ^a   Hashimoto, Joel ^a   Crabbe, John C ^a,b   Roselli, Charles E ^a   Wiren, Kristine M ^a,b   Finn, Deborah A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Alcohol; GABAA Receptors; Mouse; Neurosteroid; Radioimmunoassay

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CORTICOSTERONE; STEROID 5ALPHA REDUCTASE;

ADRENAL GLAND; AIR; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE EXPRESSION; GENETIC DIFFERENCE; GESTAGEN BLOOD LEVEL; HIPPOCAMPUS; INHALATION; LINE DIFFERENCE; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; VAPOR; WITHDRAWAL SEIZURE;

ADMINISTRATION, INHALATION; ALCOHOLISM; ANIMALS; BRAIN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HYDROCORTISONE; MALE; MICE; MICE, INBRED STRAINS; OXIDOREDUCTASES; PREGNANOLONE; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; SUBSTANCE WITHDRAWAL SYNDROME;

MUS;

EID: 70450196493     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2009.01047.x     Document Type: Article

References (61)

1. Alele PE, Devaud LL (2007) Sex differences in steroid modulation of ethanol withdrawal in male and female rats. J Pharmacol Exp Ther 320 : 427 436.
2. Barbaccia ML, Serra M, Purdy RH, Biggio G (2001) Stress and neuroactive steroids. Int Rev Neurobiol 46 : 243 272.
3. Beckley EH, Fretwell AM, Tanchuck MA, Gililland KR, Crabbe JC, Finn DA (2008) Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice. Neuropharmacology 54 : 365 374.
4. A receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J Neurosci 23 : 10013 10020.
5. A receptor. Nature Rev Neurosci 6 : 565 575.
6. Belelli D, Lan NC, Gee KW (1990) Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci Biobehav Rev 14 : 315 322.
7. Bergeson SE, Warren RK, Crabbe JC, Metten P, Erwin VG, Belknap JK (2003) Chromosomal loci influencing chronic alcohol withdrawal severity. Mamm Genome 14 : 454 463.
8. A receptor-operated chloride channels. II. Chronic effects of ethanol. J Pharmacol Exp Ther 253 : 713 719.
9. Cagetti E, Pinna G, Guidotti A, Baicy K, Olsen RW (2004) Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology 46 : 570 579.
10. Crabbe JC (1998) Provisional mapping of quantitative trait loci for chronic ethanol withdrawal severity in BXD recombinant inbred mice. J Pharmacol Exp Ther 286 : 263 271.
11. Crabbe JC, Kosobud A, Young ER, Tam BR, McSwigan JD (1985) Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav Genet 15 : 521 536.
12. Crabbe JC, Phillips TJ, Kosobud A, Belknap JK (1990) Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res 14 : 141 151.
13. Criswell HE, Breese GR (2005) A conceptualization of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology 30 : 1407 1425.
14. A receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 278 : 510 517.
15. Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM (2006a) A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev 12 : 53 76.
16. Finn DA, Crabbe JC (1999) Chronic ethanol differentially alters susceptibility to chemically induced convulsions in Withdrawal Seizure-Prone and -Resistant mice. J Pharmacol Exp Ther 288 : 782 790.
17. Finn DA, Douglass AD, Tanchuck MA, Long SL, Crabbe JC (2006b) Selected line difference in sensitivity to a GABAergic neurosteroid during ethanol withdrawal. Genes Brain Behav 5 : 53 63.
18. Finn DA, Ford MM, Wiren KW, Roselli CE, Crabbe JC (2004) The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 101 : 91 112.
19. Finn DA, Gallaher EJ, Crabbe JC (2000) Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol Exp Ther 292 : 394 405.
20. Finn DA, Gee KW (1994) The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther 271 : 164 170.
21. Gasior M, Carter RB, Witkin JM (1999) Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci 20 : 107 112.
22. Gililland-Kaufman KR, Tanchuck MA, Ford MM, Crabbe JC, Beadles-Bohling AS, Snelling C, Mark GP, Finn DA (2008) The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice. Brain Res 1243 : 113 123.
23. A receptors in the acute and chronic effects of ethanol. Psychopharmacology 139 : 2 19.
24. ® and 18S tRNA quantitation for normalizing real-time RT-PCR expression analysis. BioTechniques 36 : 54 60.
25. Hashimoto JG, Wiren KM (2008) Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology 33 : 1084 1096.
26. Hill M, Popov P, Havlíková H, Lyudmila K, Vrbíková J, Kancheva R, Pouzar V, Černý I, Stárka L (2005) Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction. Steroids 70 : 515 524.
27. Hirani K, Khisti RT, Chopde CT (2002) Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one. Neuropharmacology 43 : 1339 1350.
28. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT (2005) Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180 : 267 278.
29. Janis GC, Devaud LL, Mitsuyama H, Morrow AL (1998) Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in male and female rats. Alcohol Clin Exp Res 22 : 2055 2061.
30. Jenkins EP, Hseih CL, Milantovich A, Normington K, Berman DM, Francke U, Russell DW (1991) Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 11 : 1102 1112.
31. Kalant H, LeBlanc AE, Gibbins RJ (1971) Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol Rev 23 : 135 191.
32. Keith LD, Winslow JR, Reynolds RW (1978) A general procedure for estimation of corticosteroid response in individual rats. Steroids 31 : 523 531.
33. Krause JE, Karavolas HJ (1980) Subcellular location of hypothalamic progesterone metabolizing enzymes and evidence for distinct NADH- and NADPH-linked 3α-hydroxysteroid oxidoreductase activities. J Steroid Biochem 13 : 271 280.
34. Krieger NR, Scott RG, Jurman ME (1983) Testosterone 5α-reductase in rat brain. J Neurochem 40 : 1460 1464.
35. Melcangi RC, Poletti A, Cavarretta I, Celotti F, Colciago A, Magnaghi V, Motta M, Negri-Cesi P, Martini L (1998) The 5α-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Molec Biol 65 : 295 299.
36. Mellon S (1994) Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endo Metab 78 : 1003 1008. (Pubitemid 24143012)
37. A receptor function and gene expression in the central nervous system. Int Rev Neurobiol 38 : 1 41.
38. Morrow AL, Janis GC, VanDoren MJ, Matthews DB, Samson HH, Janak PH, Grant KA (1999) Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action? Alcohol Clin Exp Res 23 : 1933 1940.
39. Morrow AL, VanDoren MJ, Penland SN, Matthews DB (2001) The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Rev 37 : 98 109.
40. Murayama K, Zorumski CR, Izumi Y (2006) Effects of neurosteroid 3α-hydroxy-5α-pregnan-20-one on ethanol-mediated paired-pulse depression of population spikes in the CA1 region of rat hippocampal slices. Neurosci Lett 394 : 28 32.
41. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6 : 2311 2322.
42. Purdy RH, Moore PH Jr., Rao N, Hagino N, Yamaguchi T, Schmidt P, Rubinow DR, Morrow AL, Paul SM (1990a) Radioimmunoassay of 3α-hydroxy-5α- pregnan-20-one in rat and human plasma. Steroids 55 : 290 296.
43. Purdy RH, Morrow AL, Blinn JR, Paul SM (1990b) Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem 33 : 1572 1581.
44. Resko JA, Connolly PB, Roselli CE (1988) Testosterone 5α-reductase activity in neural tissue of fetal rhesus macaques. J Steroid Biochem 29 : 429 434.
45. Resko JA, Roselli CE (1992) Brain steroid synthesis and metabolism. Neuroprotocols 1 : 27 34.
46. Resko JA, Stadelman H, Handa RJ (1986) Control of 5α-reduction of testosterone in neuroendocrine tissues of female rats. Biol Reprod 34 : 870 877.
47. Roach M, Creaven P (1968) A micro-method for the determination of acetaldehyde and ethanol in blood. Clin Chim Acta 21 : 275 278.
48. Roberts AJ, Crabbe JC, Keith LD (1992) Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res 579 : 296 302.
49. Roberts AJ, Crabbe JC, Keith LD (1994) Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice. Psychopharmacology 115 : 278 284.
50. Romeo E, Brancati A, De Lorenzo A, Fucci P, Furnari C, Pompili E, Sasso GF, Spalletta G, Troisi A, Pasini A (1996) Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol 19 : 366 369.
51. Romeo E, Pompili E, di Michele F, Pace M, Rupprecht R, Bernardi G, Pasinib A (2000) Effects of fluoxetine, indomethacine and placebo on 3alpha, 5alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry 1 : 101 104.
52. Roselli CE, Snipes CA (1984) Progesterone 5α-reductase in mouse brain. Brain Res 305 : 197 202.
53. Roselli CE, Stadelman H, Horton LE, Resko JA (1987) Regulation of androgen metabolism and luteinizing hormone-releasing hormone content in discrete hypothalamic and limbic areas of male rhesus macaques. Endocrinology 120 : 97 106.
54. Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22 : 410 416.
55. A receptor activity in rat hippocampus. J Neurosci 24 : 6521 6530.
56. Silvers JM, Tokunaga S, Berry RB, White AM, Matthews DB (2003) Impairments in spatial learning and memory: ethanol, allopregnanolone, and the hippocampus. Brain Res Rev 43 : 275 284.
57. Terdal ES, Crabbe JC (1994) Indexing withdrawal in mice: matching genotypes for exposure in studies using ethanol vapor inhalation. Alcohol Clin Exp Res 18 : 542 547.
58. Tokunaga S, McDaniel JR, Morrow AL, Matthew DB (2003) Effect of acute ethanol administration and acute allopregnanolone administration on spontaneous hippocampal pyramidal cell neural activity. Brain Res 967 : 273 280.
59. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL (2000) Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 20 : 1982 1989.
60. A receptor. Curr Med Chem 16 : 455 472.
61. Winer J, Jung C, Shackel I, Williams P (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270 : 41 49.